[widget id="nav_menu-9"][widget id="text-8"][widget id="custom_html-3"]
Session Chair: Prof Marianne De Visser, The Netherlands
Inflammatory Autoimmune Myopathies
Prof Olivier Benveniste, France
30 Minutes
Genetic Therapies
Dr Kevin Flanigan, United States
30 minutes
Session Chair: Prof Bjarne Udd, Finland
MYO-SEQ, Diagnosing Patients with LGMD
Prof Volker Straub, UK
30 minutes
Metabolic Therapies
Prof John Vissing, Denmark
30 minutes
Sponsored Symposium
60 minutes
Session Chair: Prof Antonio Tascano, Italy
Novel Image Analysis to Assess Molecular Functionality of Dystrophin in Duchenne Muscular Dystrophy Clinical Trials
Mr Dominic Scaglioni, UK
20 minutes
A Dominant PYGM Mutation Causes a New Class of Glycogen Storage Diseases
Dr Jocelyn Laporte, France
20 minutes
Therapeutic potential of antagomiR-23b for treating Myotonic Dystrophy
Sra Beatriz Llamusi, Spain
20 minutes
Sponsored Symposium
60 minutes
Session Chair: Prof Peter Van Den Bergh, Belgium
Dysimmune Nodo-Paranodopathies
Dr Luis Querol, Spain
30 minutes
Painful Channelopathies
Prof Giuseppe Lauria, Italy
30 minutes
Session Chair: Dr Davide Pareyson, Italy
Charcot-Marie-Tooth and Related Neuropathies
Prof Mary Reilly, UK
30 minutes
Diabetic Neuropathy: Treatment and Costs
Dr Brian Callaghan, USA
30 minutes
Sponsored Symposium
60 minutes
Sessions Chair: Prof John England, USA
Combination of RNA-Interference and Gene Therapy to Treat Charcot-Marie-Tooth Type 2A
Dr Elena Abati, Italy
20 minutes
PDXK-Related Peripheral Neuropathy With Optic Atrophy. A New Treatable Disease
Dr Viorica Chelban, United Kingdom
20 minutes
De Novo Variants in POLR3B Cause Demyelinating Neuropathy, Ataxia, and Spasticity
Dr Djurdja Djordjevic, Canada
20 minutes
Sponsored Symposium
60 minutes
Session Chair: Prof Zohar Argov, Israel
Congenital Myasthenic Syndromes
Prof David Beeson, United Kingdom
30 minutes
Thymectomy
Dr Gil Wolfe, United States
30 minutes
Session Chair: Prof Angela Vincent, UK
Immunoactive Drug Therapy
Prof Nils Erik Gilhus, Norway
30 minutes
Drugs Related Exacerbation
Amelia Evoli, Italy
30 minutes
Sponsored Symposium
60 minutes
Session Chair: Prof Susana Quijano-Roy, France
Clinical Characteristics and Outcomes of Thymoma Associated Myasthenia Gravis
Mr Rodrigo Alvarez Velasco, Spain
20 minutes
Treatment Impact on Specific Symptom MG-ADL Domains Myasthenia Gravis Patients: Phase 2 Efgartigimod Study Analysis
Dr James Howard, United States
20 minutes
Prevalence and Associated Factors of Fatigue in the Dutch MG Population
Dr Martijn Tannemaat, Netherlands
20 minutes
Sponsored Symposium
60 minutes
Session Chair: Prof Marianne De Visser, The Netherlands
New guidelines For the Design and Implementation of ALS Clinical Trials
Prof Leonard Van Den Berg, Netherlands
30 minutes
Advances in Genetics & Epigenetic of ALS
Dr Bryan Traynor, United States
30 minutes
Session Chair: Prof Benedikt Schoser, Germany
Therapeutic Considerations in SMA 2020: Who, When and How to Treat
Dr Richard Finkel, United States
30 minutes
Newborn Screening
Prof Laurent Servais, UK
30 minutes
Sponsored Symposium
60 minutes
Session Chair: Prof Enrico Bertini, Italy
A Longitudinal Natural History Study for Type 2 and 3 Spinal Muscle Atrophy
Ms Jesica Maria Exposito Escudero, Spain
20 minutes
Cervical Spinal Cord Atrophy: An Early Marker of Survival Time in Amyotrophic Lateral Sclerosis
Miss Virginia Reyes Garrido, Spain
20 minutes
Sponsored Symposium
60 minutes
Click here to view disclosure information for individuals involved in the educational programming for ICNMDigital.
For the list of virtual industry-supported seminars (non-accredited), please visit the Virtual Industry-Supported Symposia page.
The ICNMDigital virtual library access is now closed.